Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

APOLIPOPROTEIN A - ANVISA Registration 80146501304

Access comprehensive regulatory information for APOLIPOPROTEIN A in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146501304 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including ROCHE DIAGNOSTICS GMBH, WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
2 Competitors
4 Recent Registrations
80146501304
Registration Details
ANVISA Registration Number: 80146501304
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

ABBOTT CLINICAL CHEMISTRY APOLIPOPROTEIN A1 - APOLIPOPROTEINA A1 ABBOTT BIOQUIMICA
Risk Class II

Registration Details

80146501304

25351182400200598

56998701000116

Company Information

Ireland
PT: IRLANDA

Dates and Status

Nov 07, 2005

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "APOLIPOPROTEIN A"